These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3562444)

  • 21. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
    Regul Pept; 1999 Jun; 82(1-3):19-33. PubMed ID: 10458643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
    Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
    Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
    Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
    Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
    Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
    Lhoste EF; Roebuck BD; Longnecker DS
    Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
    Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proglumide antagonizes cholecystokinin effects on plasma glucose and insulin in rats in vivo.
    Verspohl EJ; Wunderle G; Ammon HP
    Eur J Pharmacol; 1988 Jul; 152(1-2):121-8. PubMed ID: 3208828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
    von Schönfeld J; Rünzi M; Goebell H; Müller MK
    Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ornithine decarboxylase and polyamine biosynthesis in pancreatic adaptation.
    Löser C; Cleffmann U; Alves F; Fölsch UR; Creutzfeldt W
    Adv Exp Med Biol; 1988; 250():379-88. PubMed ID: 3255234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats.
    Kawanami T; Suzuki S; Yoshida Y; Kanai S; Takata Y; Shimazoe T; Watanabe S; Funakoshi A; Miyasaka K
    Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
    Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
    Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous somatostatin possibly controls pancreatic growth: further evidence for feedback regulation.
    Rünzi M; Müller MK; Goebell H
    Regul Pept; 1993 Aug; 47(1):65-72. PubMed ID: 8105514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
    Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and chronic effects of cyclosporine A on pancreatic polyamine metabolism and pancreatic adaptation.
    Löser C; Alves F; Stöckmann F; Fölsch UR; Creutzfeldt W
    Digestion; 1990; 46 Suppl 2():367-77. PubMed ID: 2262069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
    Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
    Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.